tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ALKS Stock Latest News

Alkermes price target raised to $31 from $28 at BofA
The FlyAlkermes price target raised to $31 from $28 at BofA
9d ago
ALKS
CNTA
Alkermes price target raised to $40 from $35 at Mizuho
PremiumThe Fly
Alkermes price target raised to $40 from $35 at Mizuho
10d ago
ALKS
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
15d ago
RDY
TAK
Stifel bullish on orexin, upgrades Alkermes to Buy
PremiumThe Fly
Stifel bullish on orexin, upgrades Alkermes to Buy
18d ago
TAK
ALKS
Alkermes upgraded to Buy from Hold at Stifel
PremiumThe Fly
Alkermes upgraded to Buy from Hold at Stifel
18d ago
ALKS
Alkermes price target lowered to $28 from $29 at BofA
PremiumThe FlyAlkermes price target lowered to $28 from $29 at BofA
28d ago
ALKS
Alkermes price target lowered to $43 from $48 at Cantor Fitzgerald
Premium
The Fly
Alkermes price target lowered to $43 from $48 at Cantor Fitzgerald
29d ago
ALKS
Alkermes price target lowered to $30 from $32 at Goldman Sachs
Premium
The Fly
Alkermes price target lowered to $30 from $32 at Goldman Sachs
29d ago
ALKS
Alkermes price target lowered to $37 from $38 at Piper Sandler
PremiumThe Fly
Alkermes price target lowered to $37 from $38 at Piper Sandler
29d ago
ALKS
Alkermes backs FY24 financial expectations
PremiumThe Fly
Alkermes backs FY24 financial expectations
30d ago
ALKS
Alkermes reports Q3 adjusted EPS 72c, consensus 74c
PremiumThe Fly
Alkermes reports Q3 adjusted EPS 72c, consensus 74c
30d ago
ALKS
ALKS Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
ALKS Upcoming Earnings Report: What to Expect?
1M ago
ALKS
Alkermes orexin Franchise can be ‘transformative,’ says H.C. Wainwright
PremiumThe FlyAlkermes orexin Franchise can be ‘transformative,’ says H.C. Wainwright
1M ago
ALKS
Alkermes Unveils Orexin Portfolio for Sleep Disorders
Premium
Company Announcements
Alkermes Unveils Orexin Portfolio for Sleep Disorders
1M ago
8K
ALKS
Alkermes management to meet with Piper Sandler
Premium
The Fly
Alkermes management to meet with Piper Sandler
2M ago
ALKS
Alkermes to present clinical data from its Phase 1b study of ALKS 2680
PremiumThe Fly
Alkermes to present clinical data from its Phase 1b study of ALKS 2680
2M ago
ALKS
Mizuho says hard to tell yet how Centessa and Alkermes stack up in narcolepsy
PremiumThe Fly
Mizuho says hard to tell yet how Centessa and Alkermes stack up in narcolepsy
2M ago
ALKS
CNTA
Alkermes initiates Vibrance-2 Phase 2 study evaluating ALKS 2680
PremiumThe Fly
Alkermes initiates Vibrance-2 Phase 2 study evaluating ALKS 2680
3M ago
ALKS
Fulcrum appoints Isabel Kalofonos as CCO
PremiumThe Fly
Fulcrum appoints Isabel Kalofonos as CCO
3M ago
ALKS
FULC
Alkermes price target raised to $38 from $37 at Baird
PremiumThe FlyAlkermes price target raised to $38 from $37 at Baird
4M ago
ALKS
Alkermes price target raised to $37 from $35 at H.C. Wainwright
Premium
The Fly
Alkermes price target raised to $37 from $35 at H.C. Wainwright
4M ago
ALKS
Alkermes reports Q2 non-GAAP EPS 70c, consensus 70c
Premium
The Fly
Alkermes reports Q2 non-GAAP EPS 70c, consensus 70c
4M ago
ALKS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >